Literature DB >> 18710867

Enhanced Toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children.

Franca C Hartgers1, Benedicta B Obeng, Astrid Voskamp, Irene A Larbi, Abena S Amoah, Adrian J F Luty, Daniel Boakye, Maria Yazdanbakhsh.   

Abstract

Acute Plasmodium falciparum infection is associated with strongly upregulated cytokine responses that are at least partly the result of activation of Toll-like receptors (TLRs). Whether and how TLR expression/responsiveness changes upon malarial infection is, however, currently not well understood. To assess this, we examined expression of TLRs and used the TLR ligand lipopolysaccharide (LPS) and Pam(3)Cys to stimulate peripheral blood mononuclear cells (PBMCs) from Ghanaian schoolchildren who live in a rural area where P. falciparum is endemic. Expression of TLR2 was higher, and responses to its ligand, Pam(3)Cys, were enhanced in P. falciparum-infected children compared to their uninfected counterparts. In cells from the same children, stimulation by Pam(3)Cys resulted in higher p38 mitogen-activated protein kinase activation and higher cytokine production. In vitro experiments confirmed that preincubation of PBMCs with P. falciparum-infected red blood cells enhanced responsiveness to TLR ligands. Taken together, the data indicate that P. falciparum-infected children in areas where malaria is endemic have an altered innate immune system, which might be important for the balance between immunity and pathology when new infections are encountered or when novel vaccines are introduced.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710867      PMCID: PMC2573356          DOI: 10.1128/IAI.01579-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10.

Authors:  A H van den Biggelaar; R van Ree; L C Rodrigues; B Lell; A M Deelder; P G Kremsner; M Yazdanbakhsh
Journal:  Lancet       Date:  2000-11-18       Impact factor: 79.321

Review 2.  Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications.

Authors:  Peter O Krutzik; Jonathan M Irish; Garry P Nolan; Omar D Perez
Journal:  Clin Immunol       Date:  2004-03       Impact factor: 3.969

3.  Measles vaccine coverage and immune response in children of Caiabi and Metuktire Indian tribes living in malarial endemic area: Parque indígena do Xingu, Central Brazil.

Authors:  R Spindel; R G Baruzzi; V A Souza; A W Ferreira; S L Avila
Journal:  Trop Doct       Date:  2001-07       Impact factor: 0.731

Review 4.  IL-10: the master regulator of immunity to infection.

Authors:  Kevin N Couper; Daniel G Blount; Eleanor M Riley
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

5.  Inhibition of the immune response to whooping cough and tetanus vaccines by malaria infection, and the effect of pertussis adjuvant.

Authors:  A Tarzaali; P Viens; M Quevillon
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

6.  Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children.

Authors:  Roger P Lauener; Thomas Birchler; Jill Adamski; Charlotte Braun-Fahrländer; Albrecht Bufe; Udo Herz; Erika von Mutius; Dennis Nowak; Josef Riedler; Marco Waser; Felix H Sennhauser
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

Review 7.  Pathophysiology of severe malaria in children.

Authors:  Kathryn Maitland; Kevin Marsh
Journal:  Acta Trop       Date:  2004-04       Impact factor: 3.112

8.  Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic.

Authors:  Desiree van der Kleij; Anita H J van den Biggelaar; Yvonne C M Kruize; Kim Retra; Yvonne Fillie; Marion Schmitz; Peter G Kremsner; Aloysius G M Tielens; Maria Yazdanbakhsh
Journal:  J Infect Dis       Date:  2004-03-01       Impact factor: 5.226

9.  Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children.

Authors:  Blaise Genton; Fadwa Al-Yaman; Inoni Betuela; Robin F Anders; Allan Saul; Kay Baea; Mata Mellombo; Jack Taraika; Graham V Brown; David Pye; David O Irving; Ingrid Felger; Hans-Peter Beck; Thomas A Smith; Michael P Alpers
Journal:  Vaccine       Date:  2003-12-08       Impact factor: 3.641

10.  Lower expression of TLR2 and SOCS-3 is associated with Schistosoma haematobium infection and with lower risk for allergic reactivity in children living in a rural area in Ghana.

Authors:  Franca C Hartgers; Benedicta B Obeng; Yvonne C M Kruize; Marjolijn Duijvestein; Anna de Breij; Abena Amoah; Irene A Larbi; Ronald van Ree; Michael D Wilson; Laura C Rodrigues; Daniel A Boakye; Maria Yazdanbakhsh
Journal:  PLoS Negl Trop Dis       Date:  2008-04-16
View more
  23 in total

Review 1.  Parasite virulence, co-infections and cytokine balance in malaria.

Authors:  Raquel Müller Gonçalves; Nathália Ferreira Lima; Marcelo Urbano Ferreira
Journal:  Pathog Glob Health       Date:  2014-05-23       Impact factor: 2.894

2.  Filarial lymphatic pathology reflects augmented toll-like receptor-mediated, mitogen-activated protein kinase-mediated proinflammatory cytokine production.

Authors:  Subash Babu; R Anuradha; N Pavan Kumar; P Jovvian George; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

3.  Toll-like receptor- and filarial antigen-mediated, mitogen-activated protein kinase- and NF-κB-dependent regulation of angiogenic growth factors in filarial lymphatic pathology.

Authors:  Subash Babu; R Anuradha; N Pavan Kumar; P Jovvian George; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

4.  Nyctanthes arbor-tristis positively affects immunopathology of malaria-infected mice prolonging its survival.

Authors:  Jyoti Agrawal; Karuna Shanker; Debabrata Chanda; Anirban Pal
Journal:  Parasitol Res       Date:  2013-04-30       Impact factor: 2.289

5.  Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.

Authors:  Bernardo S Franklin; Sally T Ishizaka; Marc Lamphier; Fabian Gusovsky; Hans Hansen; Jeffrey Rose; Wanjun Zheng; Marco Antônio Ataíde; Rosane B de Oliveira; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-08       Impact factor: 11.205

6.  Alterations in early cytokine-mediated immune responses to Plasmodium falciparum infection in Tanzanian children with mineral element deficiencies: a cross-sectional survey.

Authors:  Erasto V Mbugi; Marjolein Meijerink; Jacobien Veenemans; Prescilla V Jeurink; Matthew McCall; Raimos M Olomi; John F Shao; Hans Verhoef; Huub Fj Savelkoul
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

7.  The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali.

Authors:  Boubacar Traore; Younoussou Koné; Safiatou Doumbo; Didier Doumtabé; Abdramane Traoré; Peter D Crompton; Marko Mircetic; Chiung-Yu Huang; Kassoum Kayentao; Alassane Dicko; Issaka Sagara; Ruth D Ellis; Kazutoyo Miura; Agnes Guindo; Louis H Miller; Ogobara K Doumbo; Susan K Pierce
Journal:  Vaccine       Date:  2009-08-25       Impact factor: 3.641

Review 8.  Host-pathogen interactions in malaria: cross-kingdom signaling and mitochondrial regulation.

Authors:  Shirley Luckhart; Nazzy Pakpour; Cecilia Giulivi
Journal:  Curr Opin Immunol       Date:  2015-07-23       Impact factor: 7.486

9.  Malaria modifies neonatal and early-life toll-like receptor cytokine responses.

Authors:  Komi Gbédandé; Stefania Varani; Samad Ibitokou; Parfait Houngbegnon; Sophie Borgella; Odilon Nouatin; Sem Ezinmegnon; Adicatou-Laï Adeothy; Gilles Cottrell; Achille Massougbodji; Kabirou Moutairou; Marita Troye-Blomberg; Philippe Deloron; Nadine Fievet; Adrian J F Luty
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

Review 10.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.